Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review
Open Access
- 19 April 2021
- journal article
- review article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 28 (1) , 29-48
Abstract
Background: Immune-mediated demyelination and consequent degeneration of oligodendrocytes and axons are hallmark features of multiple sclerosis (MS). Remyelination declines in progressive MS, causing permanent axonal loss and irreversible disabilities. Strategies aimed at enhancing remyelination are critical to attenuate disease progression. Objective: We systematically reviewed recent advances in neuroprotective and regenerative therapies for MS, covering preclinical and clinical studies. Methods: We searched three biomedical databases using defined keywords. Two authors independently reviewed articles for inclusion based on pre-specified criteria. The data were extracted from each study and assessed for risk of bias. Results: Our search identified 7351 studies from 2014 to 2020, of which 221 met the defined criteria. These studies reported 262 interventions, wherein 92% were evaluated in animal models. These interventions comprised protein, RNA, lipid and cellular biologics, small molecules, inorganic compounds, and dietary and physiological interventions. Small molecules were the most highly represented strategy, followed by antibody therapies and stem cell transplantation. Conclusion: While significant strides have been made to develop regenerative treatments for MS, the current evidence illustrates a skewed representation of the types of strategies that advance to clinical trials. Further examination is thus required to address current barriers to implementing experimental treatments in clinical settings.Keywords
Funding Information
- The Canadian Institute of Health Research
- endMS Research Training Network
- The Multiple Sclerosis Society of Canada
- Scholar Program for Researchers in Training
This publication has 89 references indexed in Scilit:
- Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A reviewJournal of Advanced Research, 2014
- Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feedingProstaglandins, Leukotrienes and Essential Fatty Acids, 2014
- SYRCLE’s risk of bias tool for animal studiesBMC Medical Research Methodology, 2014
- Mesenchymal stem cell transplantation in multiple sclerosisJournal of the Neurological Sciences, 2013
- Oligodendrocyte Progenitor Cell Susceptibility to Injury in Multiple SclerosisThe American Journal of Pathology, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple SclerosisClinical Neuropharmacology, 2010
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?Annual Review of Neuroscience, 2008
- Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosisBrain, 2008
- Medicinal chemical properties of successful central nervous system drugsNeuroRX, 2005